Loading
AM
Acutus Medical, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hinrichs James F., was filed 17 Nov 2021.
Insider Decl.
102
Thresholds
n/a
Buy Volume
€33M
8 ops. · all time
Sell Volume
€32,369
1 ops. · all time
Since the insiders bought
- -81.4%Entry US$3.56 · Close at T+365 US$0.66
- -90.3%Entry US$16.33 · Close at T+365 US$1.58
- -90.3%Entry US$16.33 · Close at T+365 US$1.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$20.2M
Gross profitUS$1M5% margin
EBITDAUS$2.2M11% margin
Net income-US$9.5M-47.4% margin
Valuation
Beta5.77
Balance sheet & cash
Total debtUS$35.8M
Free Cash Flow-US$31.8M
Profitability & ownership
ROA-14.3%
% insiders1.3%
% institutions8.9%
Last declaration on 4 March 2024
Declarations102 total
8,475 shares@ US$0.2156.2% of flowForm 4SEC:0001628280-24-008566:0
7,582 shares@ US$0.17332.5% of flowForm 4SEC:0001628280-24-003708:0
5,709 shares@ US$0.19126.9% of flowForm 4SEC:0001628280-24-003052:0
2,869 shares@ US$0.19117.3% of flowForm 4SEC:0001628280-24-003057:0
6,342 shares@ US$0.18968.2% of flowForm 4SEC:0001628280-24-001669:0
24,086 shares@ €0.172610.1% of flowForm 4SEC:0001628280-24-001668:0
1,729 shares@ US$0.48826.5% of flowFORM 4SEC:0001628280-23-031395:0
134 shares@ US$0.695.3% of flowFORM 4SEC:0001628280-23-027854:0
433 shares@ US$0.697.3% of flowFORM 4SEC:0001628280-23-027855:0
20,000 shares0FORM 4SEC:0001628280-23-026912:0
6,484 shares0FORM 4SEC:0001628280-23-026911:0
501 shares0FORM 4SEC:0001628280-23-026910:0
8,400 shares0FORM 4SEC:0001628280-23-023903:0
8,400 shares0Common StockSEC:0001193805-23-000870:1
8,400 shares0Common StockSEC:0001193805-23-000870:0
8,400 shares0FORM 4SEC:0001628280-23-022323:0
8,400 shares0FORM 4SEC:0001628280-23-022325:0
10,920 shares0FORM 4SEC:0001628280-23-022326:0
8,400 shares0FORM 4SEC:0001628280-23-022330:0
8,400 shares0FORM 4SEC:0001628280-23-022328:0
8,400 shares0FORM 4SEC:0001628280-23-022324:0
8,400 shares0FORM 4SEC:0001628280-23-022329:0
17,290 shares@ €0.78833.0% of flowFORM 4SEC:0001628280-23-020587:0
855 shares@ US$0.75415.8% of flowFORM 4SEC:0001628280-23-010609:0
855 shares@ US$0.75447.3% of flowFORM 4SEC:0001628280-23-010610:0
25 of 102 declarations
About Acutus Medical, Inc.
One purchase dominates the record at Acutus Medical, Inc.: James E. Flynn's, a director, for EUR 4,639,458 on July 19, 2021. It accounts for nearly all purchases, which total EUR 4,771,694 across 7 purchases with an amount, out of 10 in all. James F. Hinrichs, a director, comes far behind with EUR 132,166 on November 15, 2021. The only sale, EUR 32,369, is R. Scott Huennekens's, a director, on June 3, 2022.
On August 10, 2020, 5 filers bought on the same day, right at the start of a record of 102 filings published between August 7, 2020 and March 4, 2024. It includes 81 grants and 10 filings of another kind. David Roman, President & CEO, and James E. Flynn are the most frequent with 11 filings each; David Roman has no purchase, James E. Flynn has 3. Tom Sohn signs 8, David P. Bonita 8 and Takeo Mukai (CFO) 7.
Read moreShow less
The busiest year is 2023 with 31 filings. This US health care company is listed on Nasdaq; insiders hold 1.3% of it. No filing came in the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
